Please wait a minute...
Reviews in Cardiovascular Medicine  2015, Vol. 16 Issue (3): 189-199     DOI: 10.3909/ricm0778
Review Previous articles | Next articles
Heparin: Physiology, Pharmacology, and Clinical Application
Michael S. Lee, Jeremy Kong
UCLA Medical Center, Los Angeles, CA
Download:  PDF(382KB)  ( 165 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Heparin is stored endogenously within the secretory granules of basophils and mast cells, and is only released into the vasculature at sites of injury. At these sites, it helps maintain proper blood flow by balancing the active anticoagulant and procoagulant processes. Pharmaceutical-grade heparin is derived from animal tissue, but one form is made synthetically. Heparin is commonly used in the management of coronary artery disease, deep vein thrombosis, pulmonary embolism, and atrial fibrillation, and in the prevention of thrombosis during cardiopulmonary bypass and extracorporeal membrane oxygenation. Heparin treatment is a key component in elective percutaneous coronary intervention (PCI). It plays an important role in minimizing the risk of thrombotic events during PCI and is one of the most popular anticoagulants used. However, some studies show that higher heparin doses are associated with more frequent bleeding complications, which can increase morbidity and mortality. The optimal heparin dosing regimens are still debated, as well as their efficacy in PCI compared with that of other drugs such as bivalirudin. This review examines the physiology, pharmacology, therapeutic applications, dosing regimens, and efficacy of heparin in the setting of PCI. In addition, included is a review of data on addition of glycoprotein IIb/IIIa inhibitors to heparin and comparison of heparin monotherapy to bivalirudin in PCI.
Key words:  Heparin      Percutaneous coronary intervention      Bivalirudin      Anticoagulation     
Published:  30 September 2015     

Cite this article: 

Michael S. Lee, Jeremy Kong. Heparin: Physiology, Pharmacology, and Clinical Application. Reviews in Cardiovascular Medicine, 2015, 16(3): 189-199.

URL: 

https://rcm.imrpress.com/EN/10.3909/ricm0778     OR     https://rcm.imrpress.com/EN/Y2015/V16/I3/189

[1] Federico Ronco, Giuseppe Tarantini, Peter A. McCullough. Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 9-23.
[2] En Chen, Wei Cai, Danqing Hu, Lianglong Chen. Effect of remote ischemic preconditioning in patients with STEMI during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 103-112.
[3] Ya Wang, Wen-Jing Sun, Ze-Sheng Ji, Chong-Bin Liu, Rui Wang. Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 139-145.
[4] Akanksha Agrawal, Deepanshu Jain, Pradhum Ram, Jorge Luis Penalver Leon, Janani Rangaswami. Anticoagulation for intra-cardiac thrombi in peripartum cardiomyopathy: A review of the literature[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 53-58.
[5] Christian O. Koelbl, Zoran S. Nedeljkovic, Alice K. Jacobs. Coronary Chronic Total Occlusion (CTO): A Review[J]. Reviews in Cardiovascular Medicine, 2018, 19(1): 33-39.
[6] William Finch, Michael S. Lee. Percutaneous Coronary Intervention for Coronary Bifurcation Lesions[J]. Reviews in Cardiovascular Medicine, 2017, 18(2): 59-66.
[7] Craig Basman, Michael C. Kim, Neil L. Coplan. Timing of Percutaneous Coronary Intervention and Therapeutic Hypothermia in Patients With ST-Elevation Myocardial Infarction and Out-of-hospital Cardiac Arrest[J]. Reviews in Cardiovascular Medicine, 2017, 18(2): 67-72.
[8] Nachiket Patel, Elizabeth Ngo, Timothy E. Paterick, Khawaja Afzal Ammar, Krishnaswamy Chandrasekaran, A. Jamil Tajik. ST-segment Elevation: Myocardial Infarction or Simulacrum?[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 85-99.
[9] Daniel Levin, Shweta Bansal, Anand Prasad. The Role of Novel Cardiorenal Biomarkers in the Cardiac Catheterization Laboratory for the Detection of Acute Kidney Injury[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 100-114.
[10] Ashish H. Shah, Nick Ossei-Gerning, Rito Mitra. Rotational Atherectomy in a Dissected Coronary Artery That Propagated Into the Sinus of Valsalva: Is This the Last Hope?[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 137-139.
[11] Manish Patwardhan, Sanjay Mehra, Assad Movahed, Ramesh Daggubati. Vascular Complications of Percutaneous Transradial Cardiac Catheterization[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 76-79.
[12] Sudhakar Sattur, Sorin J. Brener. The Evolution of Coronary Revascularization Appropriateness Use Criteria: From Mandatory to Forgotten[J]. Reviews in Cardiovascular Medicine, 2015, 16(4): 235-243.
[13] Carlos E. Velasco, Mahir Patel, Jaime Mogollon, Jerrold M. Grodin, Robert C. Stoler. Myocardial Infarction Related to Trauma[J]. Reviews in Cardiovascular Medicine, 2015, 16(4): 261-264.
[14] Davide Capodanno, Giuseppe Gargiulo, Giovanni Longo, Corrado Tamburino. Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 131-139.
[15] Sandeep K. Krishnan. Best of the 2014 TCT Annual Meeting[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 74-80.
No Suggested Reading articles found!